2317724
Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after herniorrhaphy
Fernando Cabrera, Todd M. Bertoch, Jessica C. McCoun, Harold S. Minkowitz, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith
Viatris, Viatris, Morgantown, WV, USA, CenExel JBR, Salt Lake City, UT, USA, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg, PA, USA, Evolution Research Group, Bellaire, Texas, USA, Viatris, Bad Homburg,...
Poster Presenter: Fernando Cabrera